Literature DB >> 11268256

Postexposure rabies prophylaxis in immunosuppressed patients.

R V Gibbons, C E Rupprecht.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11268256     DOI: 10.1001/jama.285.12.1574

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Clinical management and humoral immune responses to rabies post-exposure prophylaxis among three patients who received solid organs from a donor with rabies.

Authors:  N M Vora; L A Orciari; M Niezgoda; G Selvaggi; V Stosor; G M Lyon; R M Wallace; J Gabel; D R Stanek; P Jenkins; M Shiferaw; P Yager; F Jackson; C A Hanlon; I Damon; J D Blanton; S Recuenco; R Franka
Journal:  Transpl Infect Dis       Date:  2015-05-19       Impact factor: 2.228

2.  Rabies Vaccination in a Pediatric Patient with Acute Myeloid Leukemia during the Course of Chemotherapy: a Case report.

Authors:  Viroj Wiwanitkit
Journal:  Iran J Cancer Prev       Date:  2014

Review 3.  Travel advice for the immunocompromised traveler: prophylaxis, vaccination, and other preventive measures.

Authors:  Rupa R Patel; Stephen Y Liang; Pooja Koolwal; Frederick Matthew Kuhlmann
Journal:  Ther Clin Risk Manag       Date:  2015-02-12       Impact factor: 2.423

Review 4.  Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO).

Authors:  C T Rieger; B Liss; S Mellinghoff; D Buchheidt; O A Cornely; G Egerer; W J Heinz; M Hentrich; G Maschmeyer; K Mayer; M Sandherr; G Silling; A Ullmann; M J G T Vehreschild; M von Lilienfeld-Toal; H H Wolf; N Lehners
Journal:  Ann Oncol       Date:  2018-06-01       Impact factor: 32.976

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.